| Literature DB >> 28335618 |
Kenneth I Berns1, Nicholas Muzyczka1.
Abstract
AAV has been studied for 55 years and has been developed as a vector for about 35 years. By now, there is a fairly good idea of the dimensions of what would be useful to know to employ AAV optimally as a vector, but there are still many unanswered questions within the system. As with all biological systems, each good experiment raises further questions to answer. This article provides an overview of those areas in which unknown information can be identified and of those questions that have not yet been recognized. Some of these are touched on in the six review articles in this issue of Human Gene Therapy.Entities:
Keywords: AAV cell interactions; AAV immunity; AAV persistence; AAV toxicity
Mesh:
Year: 2017 PMID: 28335618 PMCID: PMC5399733 DOI: 10.1089/hum.2017.048
Source DB: PubMed Journal: Hum Gene Ther ISSN: 1043-0342 Impact factor: 5.695